Melt Extrusion with Poorly Soluble Drugs - An Integrated Review

Overview

Journal Int J Pharm

Specialties Chemistry
Pharmacology

Date 2017 Nov 6

PMID 29102700

Citations 67

Authors

Michael A Repka

Suresh Bandari

Venkata Raman Kallakunta

Anh Q Vo

Haley McFall

Manjeet B Pimparade

Ajinkya M Bhagurkar

Affiliations

Soon will be listed here.

Abstract

Over the last few decades, hot melt extrusion (HME) has emerged as a successful technology for a broad spectrum of applications in the pharmaceutical industry. As indicated by multiple publications and patents, HME is mainly used for the enhancement of solubility and bioavailability of poorly soluble drugs. This review is focused on the recent reports on the solubility enhancement via HME and provides an update for the manufacturing/scaling up aspects of melt extrusion. In addition, drug characterization methods and dissolution studies are discussed. The application of process analytical technology (PAT) tools and use of HME as a continuous manufacturing process may shorten the drug development process; as a result, the latter is becoming the most widely utilized technique in the pharmaceutical industry. The advantages, disadvantages, and practical applications of various PAT tools such as near and mid-infrared, ultraviolet/visible, fluorescence, and Raman spectroscopies are summarized, and the characteristics of other techniques are briefly discussed. Overall, this review also provides an outline for the currently marketed products and analyzes the strengths, weaknesses, opportunities and threats of HME application in the pharmaceutical industry.

Citing Articles

A review of precision medicine in developing pharmaceutical products: Perspectives and opportunities.

Martinez-Jimenez J, Sathisaran I, Reyes Figueroa F, Reyes S, Lopez-Nieves M, Vlaar C Int J Pharm. 2024; 670:125070.

PMID: 39689830 PMC: 11781955. DOI: 10.1016/j.ijpharm.2024.125070.

Optimizing extrusion processes and understanding conformational changes in itraconazole amorphous solid dispersions using in-line UV-Vis spectroscopy and QbD principles.

Triboandas H, Bezerra M, Almeida J, de Castro M, Santos B, Schlindwein W Int J Pharm X. 2024; 8:100308.

PMID: 39687500 PMC: 11647160. DOI: 10.1016/j.ijpx.2024.100308.

Hot-Melt Extrusion Drug Delivery System-Formulated Extracts Regulate Inflammation and Oxidative Stress in Lipopolysaccharide-Stimulated Macrophages.

Gil T, Sim H, Lee H, Ryu S, Baek J, Kim D Mar Drugs. 2024; 22(11).

PMID: 39590792 PMC: 11595552. DOI: 10.3390/md22110512.

Fabrication of Polypill Pharmaceutical Dosage Forms Using Fused Deposition Modeling 3D Printing: A Systematic Review.

Yasin H, Al-Tabakha M, Chan S Pharmaceutics. 2024; 16(10).

PMID: 39458614 PMC: 11510916. DOI: 10.3390/pharmaceutics16101285.

Surfactant-Assisted Wet Granulation-Based Matrix Tablets without Exceptional Additives: Prolonging Systemic Exposure of Model BCS Class II Ketoprofen.

Shamim R, Shafique S, Hussain K, Abbas N, Ijaz S, Bukhari N AAPS PharmSciTech. 2024; 25(7):241.

PMID: 39402222 DOI: 10.1208/s12249-024-02966-9.

References

Cosse A, Konig C, Lamprecht A, Wagner K . Hot Melt Extrusion for Sustained Protein Release: Matrix Erosion and In Vitro Release of PLGA-Based Implants. AAPS PharmSciTech. 2016; 18(1):15-26. DOI: 10.1208/s12249-016-0548-5. View

Saerens L, Dierickx L, Lenain B, Vervaet C, Remon J, De Beer T . Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process. Eur J Pharm Biopharm. 2010; 77(1):158-63. DOI: 10.1016/j.ejpb.2010.09.015. View

Pina M, Zhao M, Pinto J, Sousa J, Craig D . The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine. J Pharm Sci. 2014; 103(4):1214-23. PMC: 4241582. DOI: 10.1002/jps.23894. View

Dierickx L, Saerens L, Almeida A, De Beer T, Remon J, Vervaet C . Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices. Eur J Pharm Biopharm. 2012; 81(3):683-9. DOI: 10.1016/j.ejpb.2012.03.018. View

Adler C, Schonenberger M, Teleki A, Kuentz M . Molecularly designed lipid microdomains for solid dispersions using a polymer/inorganic carrier matrix produced by hot-melt extrusion. Int J Pharm. 2016; 499(1-2):90-100. DOI: 10.1016/j.ijpharm.2015.12.057. View

Becker W, Guschin V, Mikonsaari I, Teipel U, Kolle S, Weiss P . Turbidimetric method for the determination of particle sizes in polypropylene/clay-composites during extrusion. Anal Bioanal Chem. 2016; 409(3):741-751. DOI: 10.1007/s00216-016-0038-3. View

Johnson T, Gupta K, Fabian J, Albright T, Kiser P . Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. Eur J Pharm Sci. 2009; 39(4):203-12. DOI: 10.1016/j.ejps.2009.11.007. View

Vay K, Scheler S, Friess W . Application of Hansen solubility parameters for understanding and prediction of drug distribution in microspheres. Int J Pharm. 2011; 416(1):202-9. DOI: 10.1016/j.ijpharm.2011.06.047. View

Lakshman J, Cao Y, Kowalski J, Serajuddin A . Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Mol Pharm. 2009; 5(6):994-1002. DOI: 10.1021/mp8001073. View

10.

Cifuentes S, Lieblich M, Lopez F, Benavente R, Gonzalez-Carrasco J . Effect of Mg content on the thermal stability and mechanical behaviour of PLLA/Mg composites processed by hot extrusion. Mater Sci Eng C Mater Biol Appl. 2016; 72:18-25. DOI: 10.1016/j.msec.2016.11.037. View

11.

Luypaert J, Massart D, Vander Heyden Y . Near-infrared spectroscopy applications in pharmaceutical analysis. Talanta. 2008; 72(3):865-83. DOI: 10.1016/j.talanta.2006.12.023. View

12.

Boksa K, Otte A, Pinal R . Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion. J Pharm Sci. 2014; 103(9):2904-2910. DOI: 10.1002/jps.23983. View

13.

Stankovic M, de Waard H, Steendam R, Hiemstra C, Zuidema J, Frijlink H . Low temperature extruded implants based on novel hydrophilic multiblock copolymer for long-term protein delivery. Eur J Pharm Sci. 2013; 49(4):578-87. DOI: 10.1016/j.ejps.2013.05.011. View

14.

Fukuda M, Peppas N, McGinity J . Floating hot-melt extruded tablets for gastroretentive controlled drug release system. J Control Release. 2006; 115(2):121-9. DOI: 10.1016/j.jconrel.2006.07.018. View

15.

Challa S, Potumarthi R . Chemometrics-based process analytical technology (PAT) tools: applications and adaptation in pharmaceutical and biopharmaceutical industries. Appl Biochem Biotechnol. 2012; 169(1):66-76. DOI: 10.1007/s12010-012-9950-y. View

16.

Blagden N, De Matas M, Gavan P, York P . Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev. 2007; 59(7):617-30. DOI: 10.1016/j.addr.2007.05.011. View

17.

Prudic A, Lesniak A, Ji Y, Sadowski G . Thermodynamic phase behaviour of indomethacin/PLGA formulations. Eur J Pharm Biopharm. 2015; 93:88-94. DOI: 10.1016/j.ejpb.2015.01.029. View

18.

Pimparade M, Vo A, Maurya A, Bae J, Morott J, Feng X . Development and evaluation of an oral fast disintegrating anti-allergic film using hot-melt extrusion technology. Eur J Pharm Biopharm. 2017; 119:81-90. PMC: 5581999. DOI: 10.1016/j.ejpb.2017.06.004. View

19.

Soliva M, SPEISER P . Hot extruded dosage forms. I. Technology and dissolution kinetics of polymeric matrices. Pharm Acta Helv. 1971; 46(1):31-52. View

20.

Smith A, Kavuru P, Wojtas L, Zaworotko M, Shytle R . Cocrystals of quercetin with improved solubility and oral bioavailability. Mol Pharm. 2011; 8(5):1867-76. DOI: 10.1021/mp200209j. View